Samet Yildirim, MSc, MBS
Samet is the Head of Global Technology & Innovation Management in the Boehringer Ingelheim Biopharma Business Unit. In this role, he is co-leading the innovation strategy and over 100 projects in the global portfolio. He joined Boehringer Ingelheim in Fremont, CA in 2013 and was involved in the development of the iSKID™ continuous bioprocessing system. In 2015 he became a technology manager and developed a global innovation portfolio for the company’s Next Generation Manufacturing and Digitalization programs. Prior to Boehringer Ingelheim, Samet held various positions within responsibilities for research, product innovation and business development in life science companies. He received a BSc in Biology and an MSc in Biophysics from Ankara University and a Master of Business and Science (MBS) degree in bioprocessing from Keck Graduate Institute of California.